These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11170214)

  • 1. 1.9 A x-ray study shows closed flap conformation in crystals of tethered HIV-1 PR.
    Pillai B; Kannan KK; Hosur MV
    Proteins; 2001 Apr; 43(1):57-64. PubMed ID: 11170214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active-site mobility in human immunodeficiency virus, type 1, protease as demonstrated by crystal structure of A28S mutant.
    Hong L; Hartsuck JA; Foundling S; Ermolieff J; Tang J
    Protein Sci; 1998 Feb; 7(2):300-5. PubMed ID: 9521105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1.8A X-ray structure of C95M/C1095F double mutant of tethered HIV-1 protease dimer complexed with acetyl pepstatin.
    Prashar V; Hosur MV
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1229-35. PubMed ID: 15451428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptability and flexibility of HIV-1 protease.
    Kumar M; Hosur MV
    Eur J Biochem; 2003 Mar; 270(6):1231-9. PubMed ID: 12631281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of a tethered dimer of HIV-1 proteinase complexed with an inhibitor.
    Bhat TN; Baldwin ET; Liu B; Cheng YS; Erickson JW
    Nat Struct Biol; 1994 Aug; 1(8):552-6. PubMed ID: 7664084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.
    Strisovsky K; Tessmer U; Langner J; Konvalinka J; Kräusslich HG
    Protein Sci; 2000 Sep; 9(9):1631-41. PubMed ID: 11045610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.
    Weber IT; Wu J; Adomat J; Harrison RW; Kimmel AR; Wondrak EM; Louis JM
    Eur J Biochem; 1997 Oct; 249(2):523-30. PubMed ID: 9370363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of remote mutation on the autolysis of HIV-1 PR: X-ray and NMR investigations.
    Kumar M; Kannan KK; Hosur MV; Bhavesh NS; Chatterjee A; Mittal R; Hosur RV
    Biochem Biophys Res Commun; 2002 Jun; 294(2):395-401. PubMed ID: 12051725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observation of a tetrahedral reaction intermediate in the HIV-1 protease-substrate complex.
    Kumar M; Prashar V; Mahale S; Hosur MV
    Biochem J; 2005 Jul; 389(Pt 2):365-71. PubMed ID: 15794743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid screening for HIV-1 protease inhibitor leads through X-ray diffraction.
    Pillai B; Kannan KK; Bhat SV; Hosur MV
    Acta Crystallogr D Biol Crystallogr; 2004 Mar; 60(Pt 3):594-6. PubMed ID: 14993705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray structure of HIV-1 protease tethered dimer complexed to ritonavir.
    Das A; Rao DR; Hosur MV
    Protein Pept Lett; 2007; 14(6):565-8. PubMed ID: 17627597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV protease.
    Li M; Morris GM; Lee T; Laco GS; Wong CH; Olson AJ; Elder JH; Wlodawer A; Gustchina A
    Proteins; 2000 Jan; 38(1):29-40. PubMed ID: 10651036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance.
    Hong L; Zhang XC; Hartsuck JA; Tang J
    Protein Sci; 2000 Oct; 9(10):1898-904. PubMed ID: 11106162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for specificity of retroviral proteases.
    Wu J; Adomat JM; Ridky TW; Louis JM; Leis J; Harrison RW; Weber IT
    Biochemistry; 1998 Mar; 37(13):4518-26. PubMed ID: 9521772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A distinct binding mode of a hydroxyethylamine isostere inhibitor of HIV-1 protease.
    Dohnálek J; Hasek J; Dusková J; Petroková H; Hradilek M; Soucek M; Konvalinka J; Brynda J; Sedlácek J; Fábry M
    Acta Crystallogr D Biol Crystallogr; 2001 Mar; 57(Pt 3):472-6. PubMed ID: 11223536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site.
    Mahalingam B; Wang YF; Boross PI; Tozser J; Louis JM; Harrison RW; Weber IT
    Eur J Biochem; 2004 Apr; 271(8):1516-24. PubMed ID: 15066177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3.
    Heaslet H; Lin YC; Tam K; Torbett BE; Elder JH; Stout CD
    Retrovirology; 2007 Jan; 4():1. PubMed ID: 17212810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of equine infectious anemia virus proteinase complexed with an inhibitor.
    Gustchina A; Kervinen J; Powell DJ; Zdanov A; Kay J; Wlodawer A
    Protein Sci; 1996 Aug; 5(8):1453-65. PubMed ID: 8844837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structure of HIV-1 protease in situ product complex.
    Bihani S; Das A; Prashar V; Ferrer JL; Hosur MV
    Proteins; 2009 Feb; 74(3):594-602. PubMed ID: 18704947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation.
    Liu F; Kovalevsky AY; Louis JM; Boross PI; Wang YF; Harrison RW; Weber IT
    J Mol Biol; 2006 May; 358(5):1191-9. PubMed ID: 16569415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.